Verastem, Inc. (VSTM) Presents Results and Updated Development Plans at Annual Research and Development Day
7/12/2013 6:41:00 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today hosted its annual Research and Development Day at the Harvard Club in New York, NY.
Members of the Verastem leadership team provided an overview of the Company’s development programs targeting cancer stem cells through the inhibition of focal adhesion kinase (FAK) and PI3K/mTOR signaling pathways.
Help employers find you! Check out all the jobs and post your resume.
comments powered by